Nucala (mepolizumab) and Dupixent (dupilumab) are brand-name subcutaneous injections. They’re both prescribed for asthma and chronic rhinosinusitis with nasal polyps. Each drug may also be ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

Sanofi and Regeneron's fast-growing immunology drug Dupixent is on course for a third indication in Europe after being recommended for approval as a treatment for people with nasal polyps.

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Zerodha, one of India's leading brokerage firms, has unveiled a series of updates to its trading platform Kite, aimed at simplifying the process of order placement and enhancing user experience.

Q: Is Kites Flop or Hit? A: The performance of Kites was Flop. Q: What is the overall Box Office Collection of Kites? A: No Data Found.. Q: What is the Day 1 Box Office Collection of Kites?

21 March 2025 China's burgeoning biotech R&D capabilities are attracting increasing international attention, with non-Western countries actively seeking partnerships. At the BIOCHINA event in Suzhou ...